Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

Immunotherapy for Metastatic NSCLC - Immunity Mechanisms, Anti-PD1/PDL-1 Therapy New Standard of Care, Mechanism of Immune Checkpoint Blockade, Immuno + Chemo & Future Directions

148 views
December 13, 2018
Comments 1
Login to view comments. Click here to Login